{
  "actions": [
    {
      "acted_at": "2015-07-30", 
      "action_code": "10000", 
      "references": [], 
      "text": "Introduced in Senate", 
      "type": "action"
    }, 
    {
      "acted_at": "2015-07-30", 
      "action_code": "", 
      "committees": [
        "SSFI"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Read twice and referred to the Committee on Finance.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "s1906-114", 
  "bill_type": "s", 
  "by_request": false, 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "Senate Finance", 
      "committee_id": "SSFI"
    }
  ], 
  "congress": "114", 
  "cosponsors": [
    {
      "bioguide_id": "C000880", 
      "district": null, 
      "name": "Crapo, Mike", 
      "original_cosponsor": true, 
      "sponsored_at": "2015-07-30", 
      "state": "ID", 
      "thomas_id": "00250", 
      "title": "Sen", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2015-07-30", 
  "number": "1906", 
  "official_title": "A bill to clarify the exclusion of orphan drug sales from the calculation of the annual fee on branded prescription pharmaceutical manufacturers and importers, and for other purposes.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr3618-114", 
      "identified_by": "CRS", 
      "reason": "identical", 
      "type": "bill"
    }
  ], 
  "short_title": "Orphan Drug Fairness Act", 
  "sponsor": {
    "bioguide_id": "M000639", 
    "district": null, 
    "name": "Menendez, Robert", 
    "state": "NJ", 
    "thomas_id": "00791", 
    "title": "Sen", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2015-07-30", 
  "subjects": [
    "Drug safety, medical device, and laboratory regulation", 
    "Drug therapy", 
    "Health", 
    "Income tax credits", 
    "Prescription drugs", 
    "User charges and fees"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in Senate", 
    "date": "2015-07-30T04:00:00Z", 
    "text": "Orphan Drug Fairness Act\n\nThis bill amends the Patient Protection and Affordable Care Act (PPACA) to exclude sales of any drug or biological product approved by the Food and Drug Administration solely for rare diseases or conditions (orphan drug) from the calculation of the annual fee on manufacturers or importers with branded prescription drug sales exceeding $5 million.\n\nThis Act is effective as if included in PPACA."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Orphan Drug Fairness Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "A bill to clarify the exclusion of orphan drug sales from the calculation of the annual fee on branded prescription pharmaceutical manufacturers and importers, and for other purposes.", 
      "type": "official"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "Orphan Drug Fairness Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2016-08-01T13:30:50Z", 
  "url": "https://www.gpo.gov/fdsys/bulkdata/BILLSTATUS/114/s/BILLSTATUS-114s1906.xml"
}